Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLENZ Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.48 | -$0.48 | -$0.48 |
| Q2 2024 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q3 2024 | 3 | -$0.45 | -$0.39 | -$0.41 |
| Q1 2025 | 3 | -$0.57 | -$0.48 | -$0.51 |
| Q2 2025 | 2 | -$0.68 | -$0.68 | -$0.68 |
| Q3 2025 | 2 | -$0.64 | -$0.64 | -$0.64 |
| Q4 2025 | 2 | -$0.93 | -$0.93 | -$0.93 |
| Q1 2026 | 1 | -$0.90 | -$0.90 | -$0.90 |
| Q2 2026 | 1 | -$0.76 | -$0.76 | -$0.76 |
| Q3 2026 | 1 | -$0.65 | -$0.65 | -$0.65 |
| Q4 2026 | 1 | -$0.51 | -$0.51 | -$0.51 |
LENZ Therapeutics, Inc. Earnings Date And Information
LENZ Therapeutics, Inc. last posted its earnings results on Wednesday, November 6th, 2024. The company reported $-0.38 earnings per share for the quarter, topping analysts' consensus estimates of $-0.47 by $0.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. LENZ Therapeutics, Inc. has generated $-15 earnings per share over the last year ($-15.3 diluted earnings per share) and currently has a price-to-earnings ratio of -14.77. LENZ Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based on prior year's report dates.
LENZ Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/28/2024 | Q3 2024 | -$0.38 | $0 | $0 | ||
| 06/28/2024 | Q2 2024 | -$0.40 | $0 | $0 | ||
| 03/30/2024 | Q1 2024 | -$3.53 | $0 | |||
| 12/29/2023 | Q4 2023 | -$2.77 | $0 | |||
| 09/28/2023 | Q3 2023 | -$2.75 | $0 | |||
| 06/28/2023 | Q2 2023 | -$6.82 | $0 | |||
| 03/29/2023 | Q1 2023 | -$3.00 | $0 | |||
| 12/29/2022 | Q4 2022 | -$3.09 | $0 | |||
| 09/28/2022 | Q3 2022 | -$3.13 | $0 | |||
| 06/28/2022 | Q2 2022 | -$3.42 | $0 | |||
| 03/29/2022 | Q1 2022 | -$3.39 | $0 | |||
| 12/29/2021 | Q4 2021 | -$2.28 | $0 | |||
| 09/28/2021 | Q3 2021 | -$1.76 | $0 | |||
| 06/28/2021 | Q2 2021 | -$2.19 | $0 | |||
| 03/30/2021 | Q1 2021 | -$2.38 | $0 | |||
| 12/30/2020 | Q4 2020 | -$7.66 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.41 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.16 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.02 | $0 |
LENZ Therapeutics, Inc. Earnings: FAQ's
When is LENZ Therapeutics, Inc.'s earnings date?
LENZ Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based off last year's report dates.
Did LENZ Therapeutics, Inc. beat their earnings estimates last
quarter?
In the previous quarter, LENZ Therapeutics, Inc. (:LENZ) reported $-0.38 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.47 by $0.09.
How can I listen to LENZ Therapeutics, Inc.'s earnings conference
call?
The conference call for LENZ Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read LENZ Therapeutics, Inc.'s conference call transcript?
The conference call transcript for LENZ Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does LENZ Therapeutics, Inc. generate each year?
LENZ Therapeutics, Inc. (:LENZ) has a recorded net income of $0. LENZ Therapeutics, Inc. has generated $-15.3 earnings per share over the last four quarters.
What is LENZ Therapeutics, Inc.'s price-to-earnings ratio?
LENZ Therapeutics, Inc. (:LENZ) has a price-to-earnings ratio of -14.77 and price/earnings-to-growth ratio is -0.59.